top of page
NEWSROOM
Cedars-Sinai HerDox2.0 Nanoparticle Selected for NCL Evaluation Program
An experimental nanoparticle developed by Cedars-Sinai investigators, called HerDox2.0, has been selected for evaluation by the Nanotechnology Characterization Laboratory, a program funded by the National Cancer Institute.
Oct 151 min read
bottom of page